Xuening Li Selected Research

Xuening Li Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2016
3	Body Weight (Weight, Body) 01/2023 - 01/2022
3	Infections 01/2022 - 12/2013
2	Dyslipidemias (Dyslipidemia) 09/2021 - 01/2021
1	Inflammation (Inflammations) 01/2024
1	Infarction (Infarctions) 01/2024
1	Cerebral Infarction 01/2024
1	Pediatric Obesity 11/2023
1	Fetal Weight 10/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Headache (Headaches) 01/2023
1	Osteosarcoma (Osteogenic Sarcoma) 01/2023
1	Hypertriglyceridemia 01/2023
1	Parkinson Disease (Parkinson's Disease) 10/2022
1	Parkinsonian Disorders (Parkinsonism) 10/2022
1	Disease Progression 10/2022
1	Necrosis 05/2022
1	Ischemic Stroke 02/2022
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Hemorrhage 01/2022
1	Osteoporosis 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Birth Weight (Birth Weights) 09/2021
1	Embolic Stroke 08/2021
1	Stroke (Strokes) 08/2021
1	Hypothyroidism 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	LeptinIBA 11/2023 - 09/2021
2	tirzepatideIBA 01/2023 - 01/2022
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2015
2	LipidsIBA 09/2021 - 01/2021
2	GlucokinaseIBA 01/2017 - 01/2016
2	DorzagliatinIBA 01/2017 - 01/2016
1	fibrin fragment D (D-dimer)IBA 01/2024
1	Choline (Choline Chloride)IBA 10/2023
1	Dietary ProteinsIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	EstersIBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Liraglutide FDA Link 01/2023
1	eicosapentaenoic acid ethyl esterIBA 01/2023
1	Eicosapentaenoic AcidIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	SaponinsIBA 05/2022
1	Uric Acid (Urate)IBA 02/2022
1	CarbohydratesIBA 01/2022
1	semaglutideIBA 01/2022
1	dulaglutideIBA 01/2022
1	alirocumabIBA 01/2022
1	insulin degludecIBA 01/2022
1	evolocumabIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	Insulin Glargine (Lantus)FDA Link 01/2022
1	Denosumab FDA Link 01/2022
1	RivaroxabanIBA 01/2022
1	Proprotein Convertase 9IBA 01/2022
1	SugammadexIBA 01/2022
1	Sunitinib (Sutent)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Biological FactorsIBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	LactoferrinIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Acarbose FDA LinkGeneric 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2021
1	Cholesterol Ester Transfer ProteinsIBA 01/2021
1	anacetrapibIBA 01/2021
1	Thyroid HormonesIBA 01/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020
1	molibresibIBA 01/2020
1	mivebresibIBA 01/2020
1	Thyrotropin Alfa FDA LinkGeneric 01/2020
1	PLX51107IBA 01/2020
1	INCB054329IBA 01/2020
1	CPI-0610IBA 01/2020
1	Iodine-131IBA 01/2020
1	AZD5153IBA 01/2020
1	ODM-207IBA 01/2020
1	INCB057643IBA 01/2020

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Adjuvant Chemotherapy 01/2023
1	Exercise Therapy (Therapy, Exercise) 10/2022